Faslodex

Faslodex is a prescription medication containing fulvestrant, which belongs to a class of drugs known as estrogen receptor antagonists. It is primarily indicated for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women. By binding to and degrading the estrogen receptor, Faslodex effectively inhibits tumor growth that relies on estrogen signaling. It is administered by a healthcare professional as a slow intramuscular injection. This therapy is often used when other hormonal treatments have failed or as a first-line treatment in specific clinical scenarios determined by an oncologist.